ClinicalTrials.Veeva

Menu
R

Retina Consultants of Southern Colorado | Colorado Springs, CO

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ranibizumab
RGN-259
Razuprotafib
Tafenoquine
IONIS-FB-LRx
Fluocinolone Acetonide
Vitrase
AKB-9778

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 9 total trials

4D-150 in Patients With Diabetic Macular Edema

Phase 2 randomized, active-controlled, double-masked, dose-ranging trial in adults with Diabetic Macular Edema (DME).

Enrolling
Diabetic Macular Edema
Diabetic Retinopathy
Biological: 4D-150 IVT
Biological: Aflibercept IVT

This study will compare the efficacy and safety of HLX04-O administered by intravitreal injection (IVT) with ranibizumab in patients with active wAMD.

Active, not recruiting
Age Related Macular Degeneration
Drug: HLX04-O
Drug: ranibizumab

The objective of this study is to compare the safety and efficacy of RGN-259 to placebo for the treatment of Neurotrophic Keratopathy (NK)

Enrolling
Neurotrophic Keratopathy
Drug: Placebo
Drug: RGN-259

Trial sponsors

E
4
6
Bausch + Lomb logo
H
Ionis Pharmaceuticals logo
R
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems